Referências
Principais artigos
Hayes EB, Sejvar JJ, Zaki SR, et al. Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis. 2005;11:1174-1179. Resumo
Centers for Disease Control and Prevention. West Nile virus: guidelines for West Nile virus surveillance and control. Jul 2024 [internet publication].Texto completo
Centers for Disease Control and Prevention. West Nile virus: West Nile virus disease therapeutics: review of the literature. May 2024 [internet publication].Texto completo
Artigos de referência
1. Mostashari F, Bunning ML, Kitsutani PT, et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet. 2001;358:261-264. Resumo
2. Pridjian G, Sirois PA, McRae S, et al. Prospective study of pregnancy and newborn outcomes in mothers with West nile illness during pregnancy. Birth Defects Res A Clin Mol Teratol. 2016;106:716-723.Texto completo Resumo
3. Campbell GL, Marfin AA, Lanciotti RS, et al. West Nile virus. Lancet Infect Dis. 2002;2:519-529. Resumo
4. Petersen LR, Marfin AA. West Nile virus: a primer for the clinician. Ann Intern Med. 2002;137:173-179.Texto completo Resumo
5. Nash D, Mostashari F, Fine A, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med. 2001;344:1807-1814.Texto completo Resumo
6. Centers for Disease Control and Prevention. Provisional surveillance summary of the West Nile virus epidemic - United States, January-November 2002. MMWR Morb Mortal Wkly Rep. 2002;51:1129-1133.Texto completo Resumo
7. Centers for Disease Control and Prevention. West Nile virus: data and maps for West Nile. Jun 2024 [internet publication].Texto completo
8. Sutter RA, Lyons S, Gould CV, et al. West Nile virus and other nationally notifiable arboviral diseases - United States, 2022. MMWR Morb Mortal Wkly Rep. 2024 May 30;73(21):484-8.Texto completo Resumo
9. McDonald E, Martin SW, Landry K, et al. West Nile virus and other domestic nationally notifiable arboviral diseases - United States, 2018. MMWR Morb Mortal Wkly Rep. 2019 Aug 9;68(31):673-678.Texto completo Resumo
10. Kretschmer M, Ruberto I, Townsend J, et al. Unprecedented outbreak of West Nile virus - Maricopa County, Arizona, 2021. MMWR Morb Mortal Wkly Rep. 2023 Apr 28;72(17):452-57.Texto completo Resumo
11. European Centre for Disease Prevention and Control. Epidemiological update: West Nile virus transmission season in Europe, 2023. Feb 2024 [internet publication].Texto completo
12. Public Health England. HAIRS risk assessment: West Nile virus. Dec 2020 [internet publication].Texto completo Resumo
13. Hayes EB, Komar N, Nasci RS, et al. Epidemiology and transmission dynamics of West Nile virus disease. Emerg Infect Dis. 2005;11:1167-1173. Resumo
14. Beasley DW, Davis CT, Whiteman M, et al. Molecular determinants of virulence of West Nile virus in North America. Arch Virol Suppl. 2004;(18):35-41. Resumo
15. Groves JA, Shafi H, Nomura JH, et al. A probable case of West Nile virus transfusion transmission. Transfusion. 2017 Mar;57(3pt2):850-856. Resumo
16. Centers for Disease Control and Prevention. Laboratory-acquired West Nile virus infections - United States, 2002. MMWR Morb Mortal Wkly Rep. 2002;51:1133-1135.Texto completo Resumo
17. Iwamoto M, Jernigan DB, Guasch A, et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med. 2003;348:2196-2203.Texto completo Resumo
18. Biggerstaff BJ, Petersen LR. Estimated risk of West Nile virus transmission through blood transfusion in the United States, 2002. Transfusion. 2003;43:1007-1017. Resumo
19. Centers for Disease Control and Prevention. Intrauterine West Nile virus infection - New York, 2002. MMWR Morb Mortal Wkly Rep. 2002;51:1135-1136.Texto completo Resumo
20. Centers for Disease Control and Prevention. Possible West Nile virus transmission to an infant through breast-feeding - Michigan, 2002. MMWR Morb Mortal Wkly Rep. 2002;51:877-878.Texto completo Resumo
21. Centers for Disease Control and Prevention. West Nile virus: clinical signs and symptoms of West Nile virus disease. May 2024 [internet publication].Texto completo
22. Hayes EB, Sejvar JJ, Zaki SR, et al. Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis. 2005;11:1174-1179. Resumo
23. Sampson BA, Ambrosi C, Charlot A, et al. The pathology of human West Nile Virus infection. Hum Pathol. 2000;31:527-531. Resumo
24. Shieh WJ, Guarner J, Layton M, et al. The role of pathology in an investigation of an outbreak of West Nile encephalitis in New York, 1999. Emerg Infect Dis. 2000;6:370-372.Texto completo Resumo
25. Kumar D, Prasad GV, Zaltzman J, et al. Community-acquired West Nile virus infection in solid-organ transplant recipients. Transplantation. 2004;77:399-402. Resumo
26. Centers for Disease Control and Prevention (CDC). West Nile virus infections in organ transplant recipients - New York and Pennsylvania, August-September, 2005. MMWR Morb Mortal Wkly Rep. 2005;54:1021-1023.Texto completo Resumo
27. Centers for Disease Control and Prevention. West Nile virus: treatment and prevention of West Nile virus disease. May 2024 [internet publication].Texto completo
28. Centers for Disease Control and Prevention. West Nile virus: guidelines for West Nile virus surveillance and control. Jul 2024 [internet publication].Texto completo
29. Lee BY, Biggerstaff BJ. Screening the United States blood supply for West Nile Virus: a question of blood, dollars, and sense. PLoS Med. 2006;3:e99.Texto completo Resumo
30. Korves CT, Goldie SJ, Murray MB. Cost-effectiveness of alternative blood-screening strategies for West Nile Virus in the United States. PLoS Med. 2006;3:e21.Texto completo Resumo
31. Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee. JPAC Position Statement on West Nile Virus. August 2015 [internet publication].Texto completo
32. National Institutes of Health. NIH-funded vaccine for West Nile virus enters human clinical trials. July 2015 [internet publication].Texto completo
33. Pierce KK, Whitehead SS, Kirkpatrick BD, et al. A live attenuated chimeric West Nile virus vaccine, rWN/DEN4Δ30, is well tolerated and immunogenic in flavivirus-naive older adult volunteers. J Infect Dis. 2017 Jan 1;215(1):52-55.Texto completo Resumo
34. Chan CK, Limstrom SA, Tarasewicz DG, et al. Ocular features of West Nile virus infection in North America: a study of 14 eyes. Ophthalmology. 2006;113:1539-1546. Resumo
35. Sejvar JJ, Bode AV, Marfin AA, et al. West Nile virus-associated flaccid paralysis. Emerg Infect Dis. 2005;11:1021-1027.Texto completo Resumo
36. Miller JM, Binnicker MJ, Campbell S, et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2024 update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis. 2024 Mar 5:ciae104.Texto completo Resumo
37. Centers for Disease Control. West Nile virus: clinical testing and diagnosis for West Nile virus disease. May 2024 [internet publication].Texto completo
38. Lustig Y, Mannasse B, Koren R, et al. Superiority of West Nile virus RNA detection in whole blood for diagnosis of acute infection. J Clin Microbiol. 2016;54:2294-2297.Texto completo Resumo
39. Martin DA, Muth DA, Brown T, et al. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol. 2000;38:1823-6.Texto completo Resumo
40. Sejvar JJ, Haddad MB, Tierney BC, et al. Neurologic manifestations and outcome of West Nile virus infection. JAMA. 2003;290:511-515. Erratum in: JAMA. 2003;290:1318.Texto completo Resumo
41. Watson JT, Pertel PE, Jones RC, et al. Clinical characteristics and functional outcomes of West Nile Fever. Ann Intern Med. 2004;141:360-365. Resumo
42. Hayes EB, Gubler DJ. West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States. Ann Rev Med. 2006;57:181-194. Resumo
43. Sejvar JJ, Leis AA, Stokic DS, et al. Acute flaccid paralysis and West Nile virus infection. Emerg Infect Dis. 2003;9:788-793.Texto completo Resumo
44. Li J, Loeb JA, Shy ME, et al. Asymmetric flaccid paralysis: a neuromuscular presentation of West Nile virus infection. Ann Neurol. 2003;53:703-710. Resumo
45. Weiss D, Carr D, Kellachan J, et al. Clinical findings of West Nile virus infection in hospitalized patients, New York and New Jersey, 2000. Emerg Infect Dis. 2001 Jul-Aug;7(4):654-8.Texto completo Resumo
46. Pepperell C, Rau N, Krajden S, et al. West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario. CMAJ. 2003 May 27;168(11):1399-405. Resumo
47. Ferguson DD, Gershman K, LeBailly A, et al. Characteristics of the rash associated with West Nile virus fever. Clin Infect Dis. 2005;41:1204-1207. Resumo
48. Georges AJ, Lesbordes JL, Georges-Courbot MC, et al. Fatal hepatitis from West Nile virus. Ann Inst Pasteur Virol. 1987;138:237-244.
49. Perelman A, Stern J. Acute pancreatitis in West Nile fever. Am J Trop Med Hyg. 1974;23:1150-1152. Resumo
50. Carson PJ, Konewko P, Wold KS, et al. Long-term clinical and neuropsychological outcomes of West Nile virus infection. Clin Infect Dis. 2006;43:723-730. Resumo
51. Leis AA, Stokic DS. Neuromuscular manifestations of human West Nile virus infection. Curr Treat Options Neurol. 2005;7:15-22. Resumo
52. Jeha LE, Sila CA, Lederman RJ. West Nile virus infection: a new acute paralytic illness. Neurology. 2003;61:55-59. Resumo
53. Ahmed S, Libman R, Wesson K, et al. Guillain-Barre syndrome: an unusual presentation of West Nile virus infection. Neurology. 2000;55:144-146. Resumo
54. Roehrig JT, Nash D, Maldin B, et al. Persistence of virus-reactive serum immunoglobulin M antibody in confirmed West Nile virus encephalitis cases. Emerg Infect Dis. 2003;9:376-9.Texto completo Resumo
55. Kapoor H, Signs K, Somsel P, et al. Persistence of West Nile Virus (WNV) IgM antibodies in cerebrospinal fluid from patients with CNS disease. J Clin Virol. 2004;31:289-91. Resumo
56. Rawal A, Gavin PJ, Sturgis CD. Cerebrospinal fluid cytology in seasonal epidemic West Nile virus meningo-encephalitis. Diagn Cytopathol. 2006;34:127-129. Resumo
57. Tyler KL, Pape J, Goody RJ, et al. CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis. Neurology. 2006;66:361-365. Resumo
58. Aksamit AJ. Herpes simplex encephalitis in adults and older children. Curr Treat Options Neurol. 2005;7:145-150. Resumo
59. Cinque P, Cleator GM, Weber T, et al. The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: a consensus report. The EU Concerted Action on Virus Meningitis and Encephalitis. J Neurol Neurosurg Psychiatry. 1996;61:339-345.Texto completo Resumo
60. Luby JP. Infections of the central nervous system. Am J Med Sci. 1992;304:379-391. Resumo
61. Tsai TF. Arboviral infections in the United States. Infect Dis Clin North Am. 1991;5:73-102. Resumo
62. Fitch MT, van de Beek D. Emergency diagnosis and treatment of adult meningitis. Lancet Infect Dis. 2007;7:191-200. Resumo
63. Bicanic T, Harrison TS. Cryptococcal meningitis. Br Med Bull. 2005 Apr 18;72:99-118.Texto completo Resumo
64. Bhigjee AI, Padayachee R, Paruk H, et al. Diagnosis of tuberculous meningitis: clinical and laboratory parameters. Int J Infect Dis. 2007;11:348-354. Resumo
65. Sejvar JJ, Marfin AA. Manifestations of West Nile neuroinvasive disease. Rev Med Virol. 2006;16:209-224. Resumo
66. Wilske B, Fingerle V, Schulte-Spechtel U. Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol Med Microbiol. 2007;49:13-21. Resumo
67. Pachner AR, Steiner I. Lyme neuroborreliosis: infection, immunity, and inflammation. Lancet Neurol. 2007;6:544-552. Resumo
68. Helmick CG, Bernard KW, D'Angelo LJ. Rocky Mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases. J Infect Dis. 1984;150:480-488. Resumo
69. Biggs HM, Behravesh CB, Bradley KK, et al. Diagnosis and management of tickborne rickettsial diseases: rocky mountain spotted fever and other spotted fever group rickettsioses, ehrlichioses, and anaplasmosis - United States. MMWR Recomm Rep. 2016 May 13;65(2):1-44.Texto completo Resumo
70. Cunha BA. The atypical pneumonias: clinical diagnosis and importance. Clin Microbiol Infect. 2006 May;12 Suppl 3:12-24. Resumo
71. Tatter SB. Neurosurgical management of brain tumors. Neuroimaging Clin N Am. 1999;9:779-799. Resumo
72. Kastrup O, Wanke I, Maschke M. Neuroimaging of infections. NeuroRx. 2005;2:324-332.Texto completo Resumo
73. Castillo PR, Miller DA, Meschia JF. Choice of neuroimaging in perioperative acute stroke management. Neurol Clin. 2006;24:807-820. Resumo
74. Centers for Disease Control and Prevention. Arboviral diseases, neuroinvasive and non-neuroinvasive 2015 case definition. 2015 [internet publication].Texto completo
75. Marfin AA, Gubler DJ. West Nile encephalitis: an emerging disease in the United States. Clin Infect Dis. 2001;33:1713-9. Resumo
76. Hayes EB. West Nile virus disease in children. Pediatric Infect Dis J. 2006;25:1065-1066. Resumo
77. Rimon A, Straussberg R, Amir J. West Nile encephalitis mimicking herpes encephalitis. Pediatr Neurol. 2006;35:62-64. Resumo
78. Centers for Disease Control and Prevention. West Nile virus: West Nile virus disease therapeutics: review of the literature. May 2024 [internet publication].Texto completo
79. Chowers MY, Lang R, Nassar F, et al. Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg Infect Dis. 2001;7:675-678. Resumo
80. Hart J Jr, Tillman G, Kraut MA, et al. West Nile virus neuroinvasive disease: neurological manifestations and prospective longitudinal outcomes. BMC Infect Dis. 2014 May 9;14:248.Texto completo Resumo
81. Centers for Disease Control and Prevention. West Nile virus: possible persistence of West Nile virus infection. May 2024 [internet publication].Texto completo
82. Petersen LR, Marfin AA, Gubler DJ. West Nile virus. JAMA. 2003;290:524-528. Resumo
83. Gelfand MS. West Nile virus infection. What you need to know about this emerging threat. Postgrad Med. 2003;114:31-38. Resumo
84. Bosanko CM, Gilroy J, Wang AM, et al. West Nile virus encephalitis involving the substantia nigra: neuroimaging and pathologic findings with literature review. Arch Neurol. 2003;60:1448-1452.Texto completo Resumo
85. Johnson RT, Cornblath DR. Poliomyelitis and flaviviruses. Ann Neurol. 2003;53:691-692. Resumo
86. Zaltzman R, Klein C, Gordon CR. Opsoclonus myoclonus ataxia associated with West Nile virus infection: A dramatic presentation with benign prognosis? J Neurol Sci. 2017;376:38-41. Resumo
87. Samaan Z, McDermid Vaz S, et al. Neuropsychological Impact of West Nile virus infection: an extensive neuropsychiatric assessment of 49 cases in Canada. PLoS One. 2016;11:e0158364.Texto completo Resumo
O uso deste conteúdo está sujeito ao nosso aviso legal